Combined Anti-PLGF and Anti-Endostatin Treatments Inhibit Ocular Hemangiomas

Cellular Physiology and Biochemistry

Volumn 36, Issue 3, 2015, Pages 930-936

  Jiang, Hua ^a   Wu, Xinyi ^a   Wang, Hong ^a   Huang, Chao ^a   Zhang, Linna ^a  

^a SHANDONG UNIVERSITY   (China)

Author keywords

Endostatin; Ocular hemangiomas; Ocular neovascularization; Placental growth factor

Indexed keywords

ANTI PLACENTAL GROWTH FACTOR; CD31 ANTIGEN; ENDOSTATIN; UNCLASSIFIED DRUG; VASCULOTROPIN A; VASCULOTROPIN INHIBITOR; VASCULOTROPIN RECEPTOR 1; ANGIOGENESIS INHIBITOR; LUCIFERASE; MONOCLONAL ANTIBODY; PLACENTA PROTEIN; PLACENTAL GROWTH FACTOR;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIANGIOGENIC THERAPY; ARTICLE; BIOLUMINESCENCE; CARCINOGENESIS; COMPARATIVE STUDY; CONTROLLED STUDY; ENDOTHELIUM CELL; EYE TUMOR; GENETIC TRANSFECTION; HEMANGIOMA; HUMAN; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; OCULAR HEMANGIOMA; OUTCOME ASSESSMENT; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TREATMENT DURATION; TUMOR GROWTH; VASCULARIZATION; WESTERN BLOTTING; ANIMAL; ANTAGONISTS AND INHIBITORS; DRUG POTENTIATION; DRUG SCREENING; EYE NEOPLASMS; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; NEOVASCULARIZATION, PATHOLOGIC; NONOBESE DIABETIC MOUSE; PATHOLOGY; REPORTER GENE; SCID MOUSE;

ANGIOGENESIS INHIBITORS; ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD31; DRUG SYNERGISM; ENDOSTATINS; EYE NEOPLASMS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, REPORTER; HEMANGIOMA; HUMANS; LUCIFERASES; MALE; MICE; MICE, INBRED NOD; MICE, SCID; NEOVASCULARIZATION, PATHOLOGIC; PREGNANCY PROTEINS; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84931825197     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000430267     Document Type: Article

References (28)

1. Dubois J, Milot J, Jaeger BI, McCuaig C, Rousseau E, Powell J: Orbit and eyelid hemangiomas: Is there a relationship between location and ocular problems? Journal of the American Academy of Dermatology 2006;55:614-619.
2. Hiles DA, Pilchard WA: Corticosteroid control of neonatal hemangiomas of the orbit and ocular adnexa. Am J Ophthalmol 1971;71:1003-1008.
3. Li YJ, Jiang Q, Cao GF, Yao J, Yan B: Repertoires of autophagy in the pathogenesis of ocular diseases. Cell Physiol Biochem 2015;35:1663-1676.
4. Campochiaro PA: Ocular neovascularization. J Mol Med (Berl) 2013;91:311-321.
5. Cai X, Sezate SA, McGinnis JF: Neovascularization: Ocular diseases, animal models and therapies. Adv Exp Med Biol 2012;723:245-252.
6. Bradley J, Ju M, Robinson GS: Combination therapy for the treatment of ocular neovascularization. Angiogenesis 2007;10:141-148.
7. Campochiaro PA: Gene therapy for ocular neovascularization. Curr Gene Ther 2007;7:25-33.
8. Huo X, Li Y, Jiang Y, Sun X, Gu L, Guo W, Sun D: Inhibition of ocular neovascularization by co-inhibition of vegf-a and plgf. Cell Physiol Biochem 2015;35:1787-1796.
9. Kim S, Oh SJ, Lee J, Han J, Jeon M, Jung T, Lee SK, Bae SY, Kim J, Gil WH, Kim SW, Lee JE, Nam SJ: Berberine suppresses tpa-induced fibronectin expression through the inhibition of vegf secretion in breast cancer cells. Cell Physiol Biochem 2013;32:1541-1550.
10. Zhu X, Er K, Mao C, Yan Q Xu H, Zhang Y, Zhu J, Cui F, Zhao W, Shi H: Mir-203 suppresses tumor growth and angiogenesis by targeting vegfa in cervical cancer. Cell Physiol Biochem 2013;32:64-73.
11. Xu CW, Zhang TP, Wang HX, Yang H, Li HH: Chip enhances angiogenesis and restores cardiac function after infarction in transgenic mice. Cell Physiol Biochem 2013;31:199-208.
12. Zhang J, Wu Y, Chen A, Zhao Q: Mesenchymal stem cells promote cardiac muscle repair via enhanced neovascularization. Cell Physiol Biochem 2015;35:1219-1229.
13. Ferrara N, Gerber HP, LeCouter J: The biology of vegf and its receptors. Nat Med 2003;9:669-676.
14. Xiao X, Prasadan K, Guo P, El-Gohary Y, Fischbach S, Wiersch J, Gaffar I, Shiota C, Gittes GK: Pancreatic duct cells as a source of vegf in mice. Diabetologia 2014;57:991-1000.
15. Xiao X, Guo P, Chen Z, El-Gohary Y, Wiersch J, Gaffar I, Prasadan K, Shiota C, Gittes GK: Hypoglycemia reduces vascular endothelial growth factor a production by pancreatic beta cells as a regulator of beta cell mass. J Biol Chem 2013;288:8636-8646.
16. Zhang J, Wu Y, Chen A, Zhao Q: Mesenchymal stem cells promote cardiac muscle repair via enhanced neovascularization. Cell Physiol Biochem 2015;35:1219-1229.
17. Jia RZ, Ding GC, Gu CM, Huang T, Rui C, Wang YX, Lu Q: Cdx2 enhances htr-8/svneo trophoblast cell invasion by altering the expression of matrix metalloproteinases. Cell Physiol Biochem 2014;34:628-636.
18. Nagao H, Nakajima K, Niisato N, Hirota R, Bando H, Sakaguchi H, Hisa Y, Marunaka Y: K(+)-cl(-] cotransporter 1 (kcc1) negatively regulates ngf-induced neurite outgrowth in pc12 cells. Cell Physiol Biochem 2012;30:538-551.
19. Ma J, Sawai H, Ochi N, Matsuo Y, Xu D, Yasuda A, Takahashi H, Wakasugi T, Takeyama H: Pten regulates angiogenesis through pi3k/akt/vegf signaling pathway in human pancreatic cancer cells. Mol Cell Biochem 2009;331:161-171.
20. Cabebe E, Fisher GA: Clinical trials of vegf receptor tyrosine kinase inhibitors in pancreatic cancer. Expert Opin Investig Drugs 2007;16:467-476.
21. Hotz HG, Hines OJ, Masood R, Hotz B, Foitzik T, Buhr HJ, Gill PS, Reber HA: Vegf antisense therapy inhibits tumor growth and improves survival in experimental pancreatic cancer. Surgery 2005;137:192-199.
22. Chen Y, Jiang T, Mao A, Xu J: Esophageal cancer stem cells express plgf to increase cancer invasion through mmp9 activation. Tumour Biol 2014;35:12749-12755.
23. Zhou X, Qi Y: Plgf inhibition impairs metastasis of larynx carcinoma through mmp3 downregulation. Tumour Biol 2014;35:9381-9386.
24. Chen B, Zhang C, Dong P, Guo Y, Mu N: Molecular regulation of cervical cancer growth and invasion by vegfa. Tumour Biol 2014;35:11587-11593.
25. Mao D, Zhang Y, Lu H, Zhang H: Molecular basis underlying inhibition of metastasis of gastric cancer by anti-vegfa treatment. Tumour Biol 2014;35:8217-8223.
26. Carmeliet P, Moons L, Luttun A, Vincenti V, Compernolle V, De Mol M, Wu Y, Bono F, Devy L, Beck H, Scholz D, Acker T, DiPalma T, Dewerchin M, Noel A, Stalmans I, Barra A, Blacher S, Vandendriessche T, Ponten A, Eriksson U, Plate KH, Foidart JM, Schaper W, Charnock-Jones DS, Hicklin DJ, Herbert JM, Collen D, Persico MG: Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions. Nat Med 2001;7:575-583.
27. Eriksson A, Cao R, Pawliuk R, Berg SM, Tsang M, Zhou D, Fleet C, Tritsaris K, Dissing S, Leboulch P, Cao Y: Placenta growth factor-1 antagonizes vegf-induced angiogenesis and tumor growth by the formation of functionally inactive plgf-1/vegf heterodimers. Cancer Cell 2002;1:99-108.
28. Wang SJ, Greer P, Auerbach R: Isolation and propagation of yolk-sac-derived endothelial cells from a hypervascular transgenic mouse expressing a gain-of-function fps/fes proto-oncogene. In Vitro Cell Dev Biol Anim 1996;32:292-299.